Wedbush Reiterates Outperform Rating on BridgeBio Oncology Therapeutics, In (BBOT)
Go back to Wedbush Reiterates Outperform Rating on BridgeBio Oncology Therapeutics, In (BBOT)| (NASDAQ: BBOT) | Delayed: 8.56 +0.25 (3.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.31 | 52 Week High | $ | |||
| Open | $8.26 | 52 Week Low | $ | |||
| Day High | $8.61 | P/E | N/A | |||
| Day Low | $7.94 | EPS | $ | |||
| Volume | 269,659 | |||||

